Clinical trial
Immune Memory Evaluation in Children Following a Primary Vaccination With…
NCT00333450 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00333450 |
|---|---|
| Title | Immune Memory Evaluation in Children Following a Primary Vaccination With Pneumococcal Conjugate Vaccines. |
| Official title | Multicentre Immune Memory Study in Healthy Children Following a 3 Dose Primary Vaccination With Prevenar or GSK Biologicals' Pneumococcal Conjugate Vaccine Via the Administration of a Single Booster Dose of Pneumovax 23 |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Infections, Streptococcal |
| Intervention type | Biological |
| Interventions | Pneumococcal vaccine |
| Enrollment | 120 |
| Start date | Aug 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Jun 5, 2006 |
| Last update posted | Oct 7, 2016 |
| Countries | Germany |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: